
HCC1143 is a poorly differentiated cell line that was initiated on August 30, 1994; it took 29 months to establish.HCC1143 was derived from an invasive ductal carcinoma with no lymph node metastases.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use


Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?